Asimov, Inc.

Programming Life with Engineering Precision

Asimov is transforming biological engineering into a predictable, scalable discipline. By integrating mammalian synthetic biology, computer-aided design (CAD), and machine learning, the Boston-based startup has built a full-stack platform to program living cells. Founded in 2017 by bioengineers from MIT and Boston University, Asimov partners with over 25 companies—including top-10 pharma and biotech firms—to design and manufacture next-generation therapeutics like biologics, cell/gene therapies, and RNA. Their core mission is to bring the same rigor to genetic design that software engineers bring to code.

A Culture of Recombination and Innovation

Asimov describes its internal ethos as a "culture of recombination," where diverse backgrounds and perspectives merge to solve complex problems. The environment is highly interdisciplinary, blending wet-lab science with advanced computational modeling. Employees consistently praise the company's exciting mission and collaborative atmosphere. As one former intern noted, "Research here is insanely exciting. If you want to do synthetic biology research at a startup, either wetlab or computational, then this is the place!"

The company actively encourages exploration across technical disciplines, highlighted by initiatives like quarterly hackathons. While it maintains the fast-paced energy of a growing startup, reviews indicate that the team also values a healthy work-life balance and a supportive, friendly culture.

What You'll Actually Do

Work at Asimov varies significantly depending on your discipline, but all roles contribute to the overarching goal of building better biological tools.

For Software Engineers, the focus is on building "Kernel," Asimov's platform for designing, building, and debugging genetic systems. Engineers make architectural decisions, design GraphQL APIs using Python 3 and SQLAlchemy, and model the genuine complexity of biological systems. It's a role that requires interfacing directly with synthetic biologists to understand their workflows and create tools that transform their productivity.

For Scientists and Biologists, the day-to-day involves hands-on cell line development, transfection, cloning, and characterization using state-of-the-art equipment. Senior roles drive innovation by developing improved genetic components and optimizing processes, often managing junior scientists and representing the company at industry conferences.

Compensation & Benefits

Asimov offers competitive compensation packages tailored to experience and role. Based on current job postings, a Staff Software Engineer can expect a base salary between $179K and $230K, while a Principal Scientist in Biologics Cell Line Development ranges from $170K to $190K. An Associate Director of Strategic Alliance can earn between $185K and $206K.

Beyond base salary, the total rewards package includes stock options, a 401(k) plan (with a reported 3% match), and comprehensive medical, dental, vision, life, and disability insurance. Employees also benefit from an annual career development stipend and a robust time-off policy that features flexible/unlimited PTO and unlimited sick time.

The Interview Process

While specific details on the interview process are limited, Asimov emphasizes transparency from the start. The company notes in its job descriptions that compensation and leveling are discussed in the very first conversation. Candidates can expect a rigorous evaluation of their technical skills—whether that's deep expertise in Python and API design for software roles, or extensive experience with CHO-based cell line development for scientific positions. Given the interdisciplinary nature of the work, cross-functional communication skills and cultural fit are likely heavily weighted during the interview stages.

Why Join / Why Not

Why Join: If you are passionate about the intersection of biology and computer science, Asimov offers a rare opportunity to work at the cutting edge of synthetic biology. The company is well-funded (having raised a $175M Series B in 2023) and partners with major industry players, providing stability alongside startup agility. The interdisciplinary environment is perfect for those who want to learn outside their immediate field and contribute to tools that could revolutionize medicine.

Why Not: As a growing startup, Asimov is still evolving its internal structures. Some employee reviews have noted that promotion guidelines could be clearer and that teams can occasionally feel siloed. Additionally, the highly specialized nature of the work requires a deep commitment to solving complex, ambiguous problems, which may not suit those looking for a highly structured, predictable corporate environment.